Tag Archives: Krishna Mohan
The biopolitics of Covaxin
In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – … Continue reading
Posted in Analysis, Op-eds, Science
Tagged Balram Bhargava, Bharat Biotech, biopolitics, CDSCO, clinical trials, Covaxin, Giorgio Agamben, ICMR, Krishna Mohan
Comments Off on The biopolitics of Covaxin